Clinical Trials Logo

Solid Organ Transplant Rejection clinical trials

View clinical trials related to Solid Organ Transplant Rejection.

Filter by:
  • None
  • Page 1

NCT ID: NCT06216015 Completed - Quality of Life Clinical Trials

Exercise Training and Kidney Transplantation

RENALTX
Start date: September 30, 2015
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the physiological and molecular effects of exercise training in transplant recipients. The main questions it aims to answer are: 1. Can exercise training improve physical fitness and muscle strength in transplant recipients? 2. Can exercise training modulate inflammatory profile, hormones, lipid profile, and exercise-induced molecules in transplant recipients? 3. Can exercise training improve blood pressure and endothelial health in transplant patients? Participants will be invited to an exercise training program 6-month after their transplant surgery. Body composition, physical assessment, and blood draw will be assessed at baseline and 12-weeks after exercise or control regimen. Researchers will compare exercise group vs. routine care group to see if exercise training impact the health-related outcomes of this population.

NCT ID: NCT05215288 Available - Clinical trials for Solid Organ Transplant Rejection

Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients

Start date: n/a
Phase:
Study type: Expanded Access

This Expanded Access Protocol will provide access to the IMP ExoFlo for patients who have severe or life-threatening abdominal solid organ transplant rejection or who are evaluated and determined to be at high risk of progression to severe or life-threatening condition related to rejection of an abdominal solid organ transplant, at risk of worsening allograft function, or at risk of complications from current immunosuppressive therapeutic regimens.

NCT ID: NCT04341103 Not yet recruiting - COVID-19 Clinical Trials

AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience

Al-COVE
Start date: April 1, 2020
Phase:
Study type: Observational

The utilization of AlloSure to help guide immunosuppression management in solid organ transplant recipients diagnosed with COVID-19